Work

Phase II study of pegylated liposomal doxorubicin (PLD), low-dose dexamethasone (DEX), and lenalidomide (LEN) in patients with newly diagnosed (ND) multiple myeloma (MM)

Year: 2009

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2009.27.15_suppl.8518

Authors: R. Baz, M. A. Hussein, D. Sullivan, J. Raychaudhuri, L. Ochoa, K. Kosakowski, L. Nardelli, W. S. Dalton, M. Alsina

Institutions: Moffitt Cancer Center, Celgene (United States)

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2300603296

Cites:

Cited by:

Related to: 10